Managers / Q4 2023 · view latest →
Egerton Capital (UK) LLP
CIK 0001581811 · STRATTON HOUSE, 5 STRATTON STREET, LONDON, X0, W1J 8LA · 44(0)2074103680
Summary
Egerton Capital (UK) LLP reported $9.2B in U.S.-listed holdings across 22 positions for Q4 2023.
Its largest position, V, represents 10.3% of the portfolio.
Compared with Q3 2023, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.9% · $8.7B
- ADR · 6.1% · $560M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GEHCGE HEALTHCARE TECHNOLOGIES I | NEW | +3.50M | 3.50M | +$270M | $270M |
| CRHCRH PLC | NEW | +3.39M | 3.39M | +$235M | $235M |
| AMZNAMAZON COM INC | ADDED | +4.15M | 4.65M | +$643M | $706M |
| HLTHILTON WORLDWIDE HLDGS INC | ADDED | +662.5K | 1.30M | +$141M | $237M |
| KKRKKR & CO INC | SOLD OUT | −1.39M | 0 | −$86M | $0 |
| EGEVEREST GROUP LTD | SOLD OUT | −223.1K | 0 | −$83M | $0 |
| SLBSCHLUMBERGER LTD | TRIMMED | −6.54M | 3.30M | −$402M | $171M |
| MAMASTERCARD INCORPORATED | TRIMMED | −728.9K | 538.0K | −$272M | $229M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $9.0B | 24 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $9.2B | 23 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $9.5B | 24 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $9.7B | 25 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $8.7B | 27 | May 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $8.6B | 30 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $9.9B | 30 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $9.9B | 26 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $10.3B | 22 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $9.2B | 22 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $8.6B | 22 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $9.7B | 23 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $9.3B | 25 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $11.6B | 21 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $12.9B | 23 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $14.8B | 26 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $19.0B | 29 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $21.4B | 32 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $21.0B | 34 | Nov 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $20.1B | 31 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $19.0B | 35 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $17.7B | 34 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $16.2B | 35 | Nov 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $13.5B | 28 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $9.7B | 26 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $14.0B | 33 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $14.0B | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $13.7B | 31 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $14.2B | 26 | May 9, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $12.0B | 26 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Egerton Capital (US), LP028-22583
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.